University of Groningenfounded in 1614  -  top 100 university
Close
About us How to find us prof. dr. M.J. (Maarten) Postma

prof. dr. M.J. (Maarten) Postma

Professor Global Health Economics UMCG & RUG

prof. dr. M.J. (Maarten) Postma
Telephone:
+31 50 361 5084 (secretary)
E-mail:
m.j.postma rug.nl

Research

Research units:

Advanced
Advanced

Reset

to
1 - 50 out of 694Page size: 50
  1. 2020
  2. Dierick, B. J. H., van der Molen, T., Flokstra-de Blok, B. M. J., Muraro, A., Postma, M. J., Kocks, J. W. H., & van Boven, J. F. M. (2020). Burden and socioeconomics of asthma, allergic rhinitis, atopic dermatitis and food allergy. Expert review of pharmacoeconomics & outcomes research, 1-17. https://doi.org/10.1080/14737167.2020.1819793
  3. Tutuhatunewa, E. D., Stevens, M., Dams, O. C., van Son, J., Louhanepessy, R. D., Krabbe, P. F. M., ... Diercks, R. L. (2020). Exploring patient satisfaction after operative and nonoperative treatment for midshaft clavicle fractures: a focus group analysis. Bmc Musculoskeletal Disorders, 21(1), 1-9. [560]. https://doi.org/10.1186/s12891-020-03557-y
  4. Suwantika, A. A., Boersma, C., & Postma, M. J. (2020). The potential impact of COVID-19 pandemic on the immunization performance in Indonesia. Expert review of vaccines. https://doi.org/10.1080/14760584.2020.1800461
  5. Local Burden Dis Diarrhoea (2020). Mapping geographical inequalities in oral rehydration therapy coverage in low-income and middle-income countries, 2000-17. The Lancet Global Health, 8(8), e1038-e1060.
  6. Emamipour, S., van der Heijden, A. A. W. A., Nijpels, G., Elders, P. J. M., Beulens, J. W. J., Postma, M., ... Feenstra, T. L. (2020). A personalised screening strategy for diabetic retinopathy: a cost-effectiveness perspective. Diabetologia. https://doi.org/10.1007/s00125-020-05239-9
  7. Purba, A. K. R., Mariana, N., Aliska, G., Wijaya, S. H., Wulandari, R. R., Hadi, U., ... Postma, M. J. (2020). The burden and costs of sepsis and reimbursement of its treatment in a developing country: An observational study on focal infections in Indonesia. International Journal of Infectious Diseases, 96, 211-218. https://doi.org/10.1016/j.ijid.2020.04.075
  8. van Aalst, R., Thommes, E., Postma, M., Chit, A., & Dahabreh, I. J. (2020). On the causal interpretation of rate-change methods: the prior event rate ratio and rate difference. American Journal of Epidemiology, [kwaa122]. https://doi.org/10.1093/aje/kwaa122
  9. van Aalst, R., Russo, E. M., Neupane, N., Mahmud, S. M., Wilschut, J., Samson, S. I., ... Young-Xu, Y. (2020). Comparing the impact of high-dose versus standard dose influenza vaccines on hospitalization cost for cardiovascular and respiratory diseases: Economic assessment in the US Veteran population during 5 respiratory seasons using an instrumental variable method. Vaccine. https://doi.org/10.1016/j.vaccine.2020.05.080
  10. Gout-Zwart, J. J., de Jong, L. A., Saptenno, L., & Postma, M. J. (2020). Budget Impact Analysis of Metformin Sustained Release for the Treatment of Type 2 Diabetes in The Netherlands. PharmacoEconomics - open, 4(2), 321-330. https://doi.org/10.1007/s41669-019-00179-6
  11. Schey, C., Postma, M. J., Krabbe, P. F. M., Topachevskyi, O., Volovyk, A., & Connolly, M. (2020). Assessing the Preferences for Criteria in Multi-Criteria Decision Analysis in Treatments for Rare Diseases. Frontiers in public health, 8, [162]. https://doi.org/10.3389/fpubh.2020.00162
  12. van der Pol, S., Jong, de, L., Vemer, P., Jansen, D., & Postma, M. (2020). Response to: Defining comparators according to IQWIG’s efficiency-frontier method. Value in Health, 23(5), 675. https://doi.org/10.1016/j.jval.2019.12.013
  13. van der Pol, S., Postma, M. J., & Jansen, D. E. M. C. (2020). School health in Europe: a review of workforce expenditure across five countries. BMC Health Services Research, 20(1), [206]. https://doi.org/10.1186/s12913-020-05077-w
  14. van der Pol, S., Fens, T., Kocks, J. W. H., Postma, M., & Boven, van, J. (2020). Goed volgen nieuwe COPD-richtlijn maakt kostenbesparing mogelijk. Pharmaceutisch Weekblad, 155(10), 26-27.
  15. Arifin, B., Purba, F. D., Herman, H., Adam, J. M. F., Atthobari, J., Schuiling-Veninga, C. C. M., ... Postma, M. J. (2020). Comparing the EQ-5D-3 L and EQ-5D-5 L: studying measurement and scores in Indonesian type 2 diabetes mellitus patients. HEALTH AND QUALITY OF LIFE OUTCOMES, 18(1), [22]. https://doi.org/10.1186/s12955-020-1282-y
  16. Jacobs, M. S., Loef, B., Reidinga, A. C., Postma, M. J., Van Hulst, M., & Tieleman, R. G. (2020). Incidence, treatment and mortality of new-onset atrial fibrillation patients at the intensive care unit. Open Heart, 7(1), [001226]. https://doi.org/10.1136/openhrt-2019-001226
  17. van Aalst, R., Gravenstein, S., Mor, V., Mahmud, S. M., Wilschut, J., Postma, M., & Chit, A. (2020). Comparative effectiveness of high dose versus adjuvanted influenza vaccine: A retrospective cohort study. Vaccine, 38(2), 372-379. https://doi.org/10.1016/j.vaccine.2019.09.105
  18. FRESH AIR Collaborators, Brakema, E. A., van der Kleij, R. M., Vermond, D., van Gemert, F. A., & Kirenga, B. (2020). Let’s stop dumping cookstoves in local communities. It’s time to get implementation right. npj Primary Care Respiratory Medicine, 30(1), [3]. https://doi.org/10.1038/s41533-019-0160-8
  19. Local Burden Dis Child Growth Fail (2020). Mapping child growth failure across low- and middle-income countries. Nature, 577(7789), 231-234. https://doi.org/10.1038/s41586-019-1878-8
  20. Local Burden Dis Educ Attainment C (2020). Mapping disparities in education across low- and middle-income countries. Nature, 577, 235-238. https://doi.org/10.1038/s41586-019-1872-1
  21. Arifin, B., Probandari, A., Purba, A. K. R., Perwitasari, D. A., Schuiling-Veninga, C. C. M., Atthobari, J., ... Postma, M. J. (2020). 'Diabetes is a gift from god' a qualitative study coping with diabetes distress by Indonesian outpatients. Quality of Life Research, 29(1), 109-125. https://doi.org/10.1007/s11136-019-02299-2
  22. GBD 2017 Diarrhoeal Dis (2020). Quantifying risks and interventions that have affected the burden of diarrhoea among children younger than 5 years: an analysis of the Global Burden of Disease Study 2017. Lancet Infectious Diseases, 20(1), 37-59. https://doi.org/10.1016/S1473-3099(19)30401-3
  23. GBD Lower Resp Infect (2020). Quantifying risks and interventions that have affected the burden of lower respiratory infections among children younger than 5 years: an analysis for the Global Burden of Disease Study 2017. Lancet Infectious Diseases, 20(1), 60-79. https://doi.org/10.1016/S1473-3099(19)30410-4
  24. 2019
  25. FRESH AIR Collaborators, Brakema, E. A., Tabyshova, A., van der Kleij, R. M. J. J., Sooronbaev, T., Lionis, C., ... van Boven, J. F. M. (2019). The socioeconomic burden of chronic lung disease in low-resource settings across the globe - an observational FRESH AIR study. Respiratory Research, 20(1), [291]. https://doi.org/10.1186/s12931-019-1255-z
  26. Wondimu, A., Cao, Q., Wilschut, J. C., & Postma, M. J. (2019). Factors associated with the uptake of newly introduced childhood vaccinations in Ethiopia: the cases of rotavirus and pneumococcal conjugate vaccines. BMC Public Health, 19(1), [1656]. https://doi.org/10.1186/s12889-019-8002-8
  27. Purba, A., Ascobat, P., Muchtar, A., Wulandari, L., Dik, J-W., d’Arqom, A., & Postma, M. (2019). Cost-Effectiveness Of Culture-Based Versus Empirical Antibiotic Treatment For Hospitalized Adults With Community-Acquired Pneumonia In Indonesia: A Real-World Patient-Database Study. ClinicoEconomics and Outcomes Research, 2019(11), 729-739. https://doi.org/10.2147/CEOR.S224619
  28. Medic, G., M, K. K., Atallah, L., Weichert, J., Panda, S., Postma, M., & EL-Kerdi, A. (2019). Evidence-based Clinical Decision Support Systems for the prediction and detection of three disease states in critical care: A systematic literature review [version 2; peer review: 2 approved]. F1000Research, 8(1728). https://doi.org/10.12688/f1000research.20498.1
  29. Wasir, R., Irawati, S., Makady, A., Postma, M., Goettsch, W., Feenstra, T., & Buskens, E. (2019). The implementation of HTA in medicine pricing and reimbursement policies in Indonesia: Insights from multiple stakeholders. PLoS ONE, 14(11), [e0225626]. https://doi.org/10.1371/journal.pone.0225626
  30. Purba, A., Ascobat, P., Muchtar, A., Wulandari, L., Rosyid, A. N., Purwono, P. B., ... Postma, M. (2019). Multidrug-Resistant Infections Among Hospitalized Adults With Community-Acquired Pneumonia In An Indonesian Tertiary Referral Hospital. Infection and Drug Resistance, 2019(12), 3663-3675. https://doi.org/10.2147/IDR.S217842
  31. van der Schans, J., Hak, E., Postma, M., Breuning, L., Brouwers, J. R. B. J., Ditters, K., ... Wilffert, B. (2019). Effects of Pharmacogenetic Screening for CYP2D6 Among Elderly Starting Therapy With Nortriptyline or Venlafaxine: A Pragmatic Randomized Controlled Trial (CYSCE Trial). Journal of Clinical Psychopharmacology, 39(6), 583-590. https://doi.org/10.1097/JCP.0000000000001129
  32. Emamipour, S., van der Heijden, A. A. W. A., Postma, M., van Boven, J. F. M., & Feenstra, T. (2019). PDB34 A PERSONALIZED SCREENING STRATEGY FOR DIABETIC RETINOPATHY: A COST-EFFECTIVENESS PERSPECTIVE. Value in Health, 22, 578. https://doi.org/10.1016/j.jval.2019.09.916
  33. Wondimu, A., van der Schans, J., van Hulst, M., & Postma, M. (2019). ANALYZING SOCIO-ECONOMIC INEQUALITY IN CHILDHOOD IMMUNIZATION COVERAGE IN ETHIOPIA. Value in Health, 22(S3), S658-S658. [PIN115]. https://doi.org/10.1016/j.jval.2019.09.1356
  34. Machlaurin, A., Dolk, C., Setiawan, D., Werf, T., & Postma, M. (2019). COST EFFECTIVENESS ANALYSIS OF BACILLUS CALMETTE-GUARIN VACCINATION IN INDONESIA. Value in Health, 22(S3), S644-S644. [PIN28]. https://doi.org/10.1016/j.jval.2019.09.1272
  35. Zeevat, F., Boersma, W. G., van der Schans, J., Boersma, C., & Postma, M. (2019). COST-EFFECTIVENESS ANALYSIS ON ELDERLY PNEUMOCOCCAL VACCINATION IN THE NETHERLANDS: CHALLENGING THE DUTCH HEALTH COUNCIL'S ADVICE. Value in Health, 22(S3), S650-S650. [PIN65]. https://doi.org/10.1016/j.jval.2019.09.1306
  36. Gout-Zwart, J., Coerts, F., Gruppen, E., Gomes-Neto, A., van der Veen, Y., Oste, M., ... Postma, M. (2019). COST-EFFECTIVENESS OF INTRODUCING A DIETARY INTERVENTION FOR RENAL TRANSPLANT RECIPIENTS. Value in Health, 22(S3), S915-S915. [PUK13]. https://doi.org/10.1016/j.jval.2019.09.2697
  37. Zeevat, F., Crepey, P., Dolk, C., Postma, A. J., Breeveld-Dwarkasing, V. N. A., & Postma, M. (2019). COST-EFFECTIVENESS OF QUADRIVALENT VERSUS TRIVALENT INFLUENZA VACCINATION IN THE DUTCH NATIONAL INFLUENZA PREVENTION PROGRAM. Value in Health, 22(S3), S647-S647. [PIN44]. https://doi.org/10.1016/j.jval.2019.09.1287
  38. Zeevat, F., Luttjeboer, J., Beutels, P., Boersma, C., & Postma, M. (2019). EXPLORATORY ANALYSIS OF THE ECONOMICALLY JUSTIFIABLE PRICE OF AN RSV VACCINE FOR THE ELDERLY IN THE NETHERLANDS AND THE UNITED KINGDOM. Value in Health, 22(S3), S643-S644. [PIN25]. https://doi.org/10.1016/j.jval.2019.09.1269
  39. Wasir, R., Postma, M., van der Schans, J., Mukti, A. G., & Buskens, E. (2019). IMPLEMENTATION OF UNIVERSAL HEALTH COVERAGE IN INDONESIA. Value in Health, 22(S3), S782-S782. [PNS123]. https://doi.org/10.1016/j.jval.2019.09.2024
  40. van Beekhuizen, S., Ouwens, D. M., Postma, M., & Heeg, B. (2019). NEW METHODOLOGIES IN PARAMETRIC NETWORK META-ANALYSIS: ACCOUNTING FOR POPULATION AGE DIFFERENCES BETWEEN TRIALS. Value in Health, 22(S3), S517-S517. [PCN420]. https://doi.org/10.1016/j.jval.2019.09.613
  41. van Beekhuizen, S., Ouwens, M. J., Pham, H. A., Postma, M., & Heeg, B. (2019). NEW METHODOLOGY IN PARAMETRIC NETWORK META-ANALYSIS: NON-MIXTURE CURE MODELS. Value in Health, 22(S3), S523-S523. [PCN447]. https://doi.org/10.1016/j.jval.2019.09.639
  42. Al Khayat, M., Eijsink, J., Postma, M., Wilschut, J. C., & van Hulst, M. (2019). THE COST-EFFECTIVENESS OF HEPATITIS C VIRUS SCREENING AND TREATMENT STRATEGIES AMONG RECENTLY ARRIVED MIGRANTS FOR THE NETHERLANDS. Value in Health, 22(S3), S651-S651. https://doi.org/10.1016/j.jval.2019.09.1309
  43. Wigfield, P., Ouwens, D. M., Vincken, T., Postma, M., & Heeg, B. (2019). THE IMPACT OF USING AGGREGATE DATA FOR MULTISTATE MODELLING PURPOSES IN ECONOMIC EVALUATIONS. Value in Health, 22(S3), S407-S408. [CP1]. https://doi.org/10.1016/j.jval.2019.09.057
  44. Hashim, M., Hardtstock, F., Cizova, D., Maywald, U., Postma, M., Heeg, B., & Wilke, T. (2019). TIME-TO-TREATMENT DISCONTINUATION (TTD) AS A PRAGMATIC PREDICTOR OF OVERALL SURVIVAL (OS) IN FIRST-LINE ADVANCED NON-SMALL CELL LUNG CANCER (ANSCLC) - REAL-WORLD PERSPECTIVE. Value in Health, 22(S3), S414-S414. [ON7]. https://doi.org/10.1016/j.jval.2019.09.087
  45. Wondimu, A., Almansa, J., Cao, Q., van Hulst, M., & Postma, M. (2019). UNDERSTANDING CHANGES IN FULL CHILDHOOD IMMUNIZATION COVERAGE IN ETHIOPIA BETWEEN 2000 AND 2016: OAXACA-BLINDER DECOMPOSITION ANALYSIS. Value in Health, 22(S3), S658-S658. [PIN114]. https://doi.org/10.1016/j.jval.2019.09.1355
  46. Arifin, B., van Asselt, A. D. I., Setiawan, D., Atthobari, J., Postma, M. J., & Cao, Q. (2019). Diabetes distress in Indonesian patients with type 2 diabetes: a comparison between primary and tertiary care. BMC Health Services Research, 19(1), [773]. https://doi.org/10.1186/s12913-019-4515-1
  47. Claassens, D. M. F., Vos, G. J. A., Bergmeijer, T. O., Hermanides, R. S., van 't Hof, A. W. J., van der Harst, P., ... ten Berg, J. M. (2019). A Genotype-Guided Strategy for Oral P2Y(12) Inhibitors in Primary PCI. New England Journal of Medicine, 381(17), 1621-1631. https://doi.org/10.1056/NEJMoa1907096
  48. Zeevat, F., van der Schans, J., Boersma, W. G., Boersma, C., & Postma, M. J. (2019). Cost-effectiveness analysis on elderly pneumococcal vaccination in the Netherlands: Challenging the Dutch Health Council's advice. Vaccine, 37(43), 6282-6284. https://doi.org/10.1016/j.vaccine.2019.08.051
  49. van der Pol, S., de Jong, L. A., Vemer, P., Jansen, D. E. M. C., & Postma, M. (2019). Cost-Effectiveness of Sacubitril/Valsartan in Germany: An Application of the Efficiency Frontier. Value in Health, 22(10), 1119-1127. https://doi.org/10.1016/j.jval.2019.06.007
  50. Fens, T., van der Pol, S., Kocks, J. W. H., Postma, M. J., & van Boven, J. F. M. (2019). Economic Impact of Reducing Inappropriate Inhaled Corticosteroids Use in Patients With Chronic Obstructive Pulmonary Disease: ISPOR’s guidance on budget impact in practice . Value in Health, 22(10), 1092-1101. https://doi.org/10.1016/j.jval.2019.05.006
  51. van de Hei, S. J., Poot, C. C., Meijer, E., Metting, E. I., Postma, M. J., Van Boven, J. F. M., ... Kocks, J. W. H. (2019). Effectiveness and acceptability of a smart inhaler asthma self-management programme: a cluster RCT study protocol. European Respiratory Journal, 54. https://doi.org/10.1183/13993003.congress-2019.PA3995
  52. Global Burden of Disease Cancer Collaboration (2019). Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study. JAMA oncology, 5(12), 1749-1768. https://doi.org/10.1001/jamaoncol.2019.2996
Previous 1 2 3 4 5 6 7 8 ...14 Next

ID: 193217

University of Groningen staff: edit these data

print
Follow the UGfacebook twitter linkedin rss instagram youtube